Cookies help us deliver the best experience on our website. Click the 'I Consent' button to enable cookies and access the site.

Learn More

Higher Scientific Officer - Targeted Therapy Team

Job Details
Closing Date: 2021-08-02
Institution: Institute of Cancer Research
Term: 2 years
Keyword Names: Cancer/Oncology, Academic/Research, Scientific Officer
Salary: £32,000
Line 1: Institute of Cancer Research
City: London
Country: United Kingdom

Job Description

Higher Scientific Officer - Targeted Therapy Team

The Institute of Cancer Research, London, UK

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top five cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer. Vacancy Description  

We are seeking a Higher Scientific Officer, to join the Targeted Therapy Team within the Division of Radiotherapy & Imaging. The post-holder will provide skilled laboratory assistance in pre-clinical projects in immunotherapy research. The laboratory work will include cell culture as well as analyses of in vivo samples by in vitro and ex vivo assays. Techniques used will include standard molecular biology assays such as DNA / RNA preparations, PCRs and ELISAs as well as multicolour flow cytometry and other functional immunology assays. The successful candidate will also be expected to contribute to the design and development of on-going research projects.

The targeted therapy team are a translational research team, led by Professor Kevin Harrington, with interest in ways to activate the immune system to target cancer, for example by using radiotherapy, oncolytic viruses or innate immune agonists. We undertake research to identify mechanisms of action behind successful combination therapy strategies. Areas of activity include thyroid cancer, head and neck cancer and melanoma.

Applications should be made via the e-recruitment system on the ICR website. When applying please upload your CV and a supporting statement outlining why you would be suitable for this position including how you meet the person specification and give the names and contact details of two referees. 

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.

The ICR is the leading academic research centre in the UK. Effective industry collaboration and innovation in new medicines and technologies are at the heart of our approach to drive benefits for patients. The ICR is ranked:

  • first for the quality and impact of our research*
  • second worldwide for the number of our publications cited in patents**
  • fourth worldwide for the citation rate of scientific research published across all fields**
  • fourth worldwide for top-cited research publications**
  • in the top five higher education institutions worldwide for academic influence and commercial impact**

Job Description and Person Specification   Final_JD_HSO_Harrington.pdf – 312KB